Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share Price

Price 8.00p on 25-07-2025 at 18:50:04
Change -0.10p -1.23%
Buy 8.50p
Sell 7.50p
Last Trade: Unknown 270,000.00 at 8.00p
Day's Volume: 995,907
Last Close: 8.00p
Open: 8.30p
ISIN: GB00B02LCQ05
Day's Range 8.00p - 8.50p
52wk Range: 3.88p - 8.50p
Market Capitalisation: £381.32m
VWAP: 8.184983p
Shares in Issue: 4.77b

Allergy Thera. (AGY) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 270,000 8.00p Uncrossing Trade
16:35:09 - 25-Jul-25
Sell* 800 7.95p Ordinary
15:57:11 - 25-Jul-25
Buy* 10,000 8.50p Suspected BUY Trade
14:00:15 - 25-Jul-25
Buy* 1,111 8.175p Ordinary
13:43:23 - 25-Jul-25
Buy* 12,429 8.05p Ordinary
11:18:50 - 25-Jul-25
Buy* 5,000 8.50p Suspected BUY Trade
11:00:07 - 25-Jul-25
Unknown* 120,000 8.00p Ordinary
10:52:43 - 25-Jul-25
Unknown* 190,000 8.50p Negotiated Trade
10:52:25 - 25-Jul-25
Unknown* 150,000 8.00p Ordinary
10:51:51 - 25-Jul-25
Unknown* 150,000 8.50p Negotiated Trade
10:02:53 - 25-Jul-25
See more Allergy Thera. trades

Allergy Thera. (AGY) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jul 2025 (Fri) 8.30 8.50 8.00 8.00 995,907
24th Jul 2025 (Thu) 8.20 8.50 8.10 8.10 571,522
23rd Jul 2025 (Wed) 8.20 8.50 8.00 8.00 447,599
22nd Jul 2025 (Tue) 8.10 8.25 8.00 8.00 666,418
21st Jul 2025 (Mon) 7.85 8.00 7.50 8.00 806,659
18th Jul 2025 (Fri) 8.20 8.30 7.875 8.30 186,651
17th Jul 2025 (Thu) 8.25 8.25 7.875 8.00 238,837
16th Jul 2025 (Wed) 7.90 8.30 7.875 8.25 88,429
15th Jul 2025 (Tue) 8.20 8.20 7.75 8.00 482,513
14th Jul 2025 (Mon) 8.00 8.30 7.875 8.00 575,978
11th Jul 2025 (Fri) 8.30 8.30 7.75 8.25 617,367
10th Jul 2025 (Thu) 8.00 8.25 7.75 8.25 179,228
9th Jul 2025 (Wed) 8.10 8.10 8.00 8.00 201,344
8th Jul 2025 (Tue) 8.00 8.10 7.625 8.10 260,751
7th Jul 2025 (Mon) 8.00 8.00 7.625 8.00 306,831
4th Jul 2025 (Fri) 8.00 8.00 7.625 8.00 54,420
3rd Jul 2025 (Thu) 8.00 8.00 7.625 8.00 75,178
2nd Jul 2025 (Wed) 8.00 8.00 7.625 8.00 150,467
1st Jul 2025 (Tue) 8.00 8.00 7.25 8.00 584,082
30th Jun 2025 (Mon) 7.25 7.95 7.25 7.95 1,035,651
27th Jun 2025 (Fri) 7.45 7.45 7.30 7.30 491,444
26th Jun 2025 (Thu) 7.85 7.85 7.125 7.30 1,502,243
See more Allergy Thera. price history

Allergy Thera. (AGY) Share News

Allergy Therapeutics shares slump as expects to post revenue decline

21st Jul 2025 13:47

(Alliance News) - Allergy Therapeutics PLC on Monday said it expects to report a small decline in earnings during its most recent financial year, as a result of regulatory changes within its key German market. Read More

LONDON MARKET OPEN: London stocks climb as miners and gold shine

21st Jul 2025 08:58

(Alliance News) - European equities were muted at the market open on Monday, beaten by the FTSE 100 as the index passed the 9,000 mark on a boost from miners. Read More

Allergy Therapeutics half-year loss narrows on lower expenses

31st Mar 2025 12:24

(Alliance News) - Allergy Therapeutics PLC on Monday said talks are underway regarding further financing as it said reduced costs helped trim its half-year loss. Read More

Allergy Therapeutics peanut allergy vaccine trial enters final phase

27th Mar 2025 18:27

(Alliance News) - Allergy Therapeutics PLC on Thursday said its peanut allergy vaccine trial has entered the final treatment phase. Read More

IN BRIEF: Allergy Therapeutics expects annual sales to rise on-year

28th Jan 2025 21:19

Allergy Therapeutics PLC - Sussex, England-based biotechnology company - Expects revenue to rise by 1.1%, or by 4% at constant currency, to GBP34.0 million in the six months ended December from GBP33.6 million a year ago. Sales are expected to continue to grow in the second half of the financial year. Overall, expects sales for the full year ending June 30 to exceed sales in the corresponding period ended June 2024. Reports cash position of GBP21.7 million at the end of December, rising from GBP12.9 million a year ago, following receipt of new GBP20 million five-year term loan. Chief Executive Manuel Llobet says: "We enter 2025 building strong momentum across all aspects of our business. Our return to first-half growth and strengthened position, having secured the Hayfin facility in late 2024, give us the confidence and financial stability to further our ambitious strategy." Read More

See more Allergy Thera. news
FTSE 100 Latest
Value9,120.31
Change-18.06

Login to your account

Forgot Password?

Not Registered